End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4,620 IDR | +0.87% | -8.06% | -27.81% |
Summary
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- With a P/E ratio at 10.67 for the current year and 9.03 for next year, earnings multiples are highly attractive compared with competitors.
- With regards to fundamentals, the enterprise value to sales ratio is at 769.37 for the current period. Therefore, the company is undervalued.
- The company appears to be poorly valued given its net asset value.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- The company is one of the best yield companies with high dividend expectations.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Construction Materials
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-27.81% | 1.92B | B+ | ||
+17.69% | 48.69B | B | ||
+1.22% | 15.9B | B+ | ||
-4.04% | 15.47B | D+ | ||
-14.69% | 10.44B | B+ | ||
+26.59% | 8.9B | D | ||
+4.79% | 8.38B | C+ | ||
+105.28% | 8.12B | - | ||
-8.03% | 7.48B | B+ | ||
+24.26% | 6.8B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SMGR Stock
- Ratings PT Semen Indonesia (Persero) Tbk